Fiche publication
Date publication
avril 2020
Journal
BMC pregnancy and childbirth
Auteurs
Membres identifiés du Cancéropôle Est :
Dr MARCAIS Ambroise
Tous les auteurs :
Cotteret C, Pham YV, Marcais A, Driessen M, Cisternino S, Schlatter J
Lien Pubmed
Résumé
Hodgkin lymphoma (HL) is the most common hematological malignancy during pregnancy. The first-line treatment for HL in pregnancy is the standard ABVD regimen without any drug and/or dose adjustment. However, data on chemotherapy during twin pregnancies are sparse, and a better understanding of the mechanisms involved in exposure to and the toxic effects of anticancer drugs in the fetuses is needed.
Mots clés
Cardiotoxicity, Doxorubicin, Fetus, Hodgkin lymphoma, Twin dizygotic pregnancy
Référence
BMC Pregnancy Childbirth. 2020 04 19;20(1):231
